Globus Medical (GMED) Finished Goods (2018 - 2025)

Globus Medical (GMED) has reported Finished Goods for 8 consecutive years, with $555.7 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Finished Goods changed 0.46% year-over-year to $555.7 million; the trailing twelve-month figure through Sep 2025 stood at $555.7 million (changed 0.46% YoY), and the FY2024 full-year result was $491.5 million, down 30.53% from the prior year.
• Finished Goods was little changed at $555.7 million in Q3 2025 per GMED's latest filing, from $558.4 million in the prior quarter.
• Across five years, Finished Goods topped out at $769.7 million in Q3 2023 and bottomed at $172.1 million in Q3 2021.
• Historically, Finished Goods has averaged $390.0 million across 5 years, with a median of $237.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Finished Goods surged 273.12% in 2023, then plunged 30.53% in 2024.
• Over 5 years, Finished Goods stood at $177.8 million in 2021, then climbed by 23.72% to $220.0 million in 2022, then jumped by 221.64% to $707.5 million in 2023, then slumped by 30.53% to $491.5 million in 2024, then climbed by 13.08% to $555.7 million in 2025.
• According to Business Quant data, Finished Goods over the past three periods registered $555.7 million, $558.4 million, and $497.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.